GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CordovaCann Corp (XCNQ:CDVA) » Definitions » Research & Development

CordovaCann (XCNQ:CDVA) Research & Development : C$0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is CordovaCann Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. CordovaCann's Research & Development for the six months ended in Jun. 2023 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.

CordovaCann Research & Development Historical Data

The historical data trend for CordovaCann's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CordovaCann Research & Development Chart

CordovaCann Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CordovaCann Semi-Annual Data
Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CordovaCann Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CordovaCann  (XCNQ:CDVA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CordovaCann Research & Development Related Terms

Thank you for viewing the detailed overview of CordovaCann's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

CordovaCann (XCNQ:CDVA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CordovaCann Corp (XCNQ:CDVA) » Definitions » Research & Development
Comparable Companies
RAPH CRYM ALIM EDXC CPIX FLGC RLBD ALID LSDI CYTH ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 SZSE:000538 TSE:4507 VTRS NSE:DIVISLAB
Traded in Other Exchanges
LVRLF:USA
Address
217 Queen Street West, Suite 401, Toronto, ON, CAN, M5V0R2
Website
https://www.cordovacann.com
CordovaCann Corp is a Canadian-domiciled company focused on building a diversified cannabis company. The company provides services and investment capital to the processing and production of vertical markets of the cannabis industry.
Executives
Benjamin Thomas Higham Director

CordovaCann (XCNQ:CDVA) Headlines

No Headlines